| Endocrine and targeted therapy for hormone-receptor-positive, HER2-negative advanced breast cancer: insights to sequencing treatment and overcoming resistance based on clinical … R El Sayed, L El Jamal, S El Iskandarani, J Kort, M Abdel Salam, H Assi Frontiers in oncology 9, 510, 2019 | 79 | 2019 |
| Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction PS Rana, DC Soler, J Kort, JJ Driscoll Frontiers in Cell and Developmental Biology 10, 1059715, 2022 | 15 | 2022 |
| Characteristics of lupus and lupus nephritis at a tertiary care center in Lebanon SH Koubar, J Kort, S Kawtharani, M Chaaya, M Makki, I Uthman Lupus 28 (13), 1598-1603, 2019 | 12 | 2019 |
| Road testing new CAR design strategies in multiple myeloma PS Rana, EV Murphy, J Kort, JJ Driscoll Frontiers in Immunology 13, 957157, 2022 | 8 | 2022 |
| Safety and efficacy of four cycles of Brentuximab Vedotin as consolidation after autologous peripheral stem cell transplantation in relapsed/refractory Hodgkin lymphoma J Kort, A Chidiac, R El Sayed, R Massoud, R Nehme, A Bazarbachi, ... Leukemia & Lymphoma 61 (7), 1732-1735, 2020 | 8 | 2020 |
| Safety and Efficacy of replacing vindesine with vincristine in R-ACVBP regimen for the treatment of large B cell lymphomas R El Sayed, H El Darsa, J Kort, F Al Chami, A Ibrahim, M Charafeddine, ... Clinical Lymphoma Myeloma and Leukemia 21 (10), 711-719, 2021 | 3 | 2021 |
| Prognostic Value of Dynamic Monoclonal Protein Pattern on Probability of Myeloma Progression from the Precursor State J Kort, R Kyasaram, S Cao, P Fu, JJ Driscoll, E Malek Blood 138, 3781, 2021 | 1 | 2021 |
| Safety and Efficacy of Modified R-ACVBP for the Treatment of High-Grade B Cell Lymphoma: Experience of a Tertiary Center in Lebanon R El Sayed, H Darsa, J Kort, J El Cheikh, A Bazarbachi Clinical Lymphoma, Myeloma and Leukemia 19, S257-S258, 2019 | 1 | 2019 |
| Dose-Adjusted Melphalan Yields Comparable MRD-Negativity to Full-Dose Melphalan in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant J Kort, J Ignatz-Hoover, F Oley, B Cooper Clinical Lymphoma Myeloma and Leukemia 24, S246, 2024 | | 2024 |
| MM-746 Dose-Adjusted Melphalan Yields Comparable MRD-Negativity to Full-Dose Melphalan in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplant J Kort, J Ignatz-Hoover, F Oley, B Cooper Clinical Lymphoma Myeloma and Leukemia 24, S582-S583, 2024 | | 2024 |
| Effect of dose-adjusted melphalan on MRD-negativity to full dose melphalan in patients with multiple myeloma post-autologous stem cell transplant. J Kort, JJ Ignatz-Hoover, N Naleid, F Oley, BW Cooper Journal of Clinical Oncology 42 (16_suppl), 7557-7557, 2024 | | 2024 |
| Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial E Malek, J Kort, L Metheny, P Fu, G Li, P Hari, Y Efebera, NS Callander, ... Transplantation and Cellular Therapy, 2024 | | 2024 |
| Assessing a New Paradigm in Defining High Risk Precursor Disease State for Patients with Plasma Cell Dyscrasia: Fluctuating Monoclonal Protein R Chopra, P Fu, J Kort, R Kyasaram, E Malek Blood 142, 6774, 2023 | | 2023 |
| Assessing the Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT) in Risk-Stratifying Multiple Myeloma Patients for Autologous Stem Cell Transplantation J Kort, SS Areti, N Naleid, BW Cooper, E Malek Blood 142, 6706, 2023 | | 2023 |
| MM-537 Impact of Melphalan Dose and CD34+ Cell Infusion on Engraftment and Post-Transplant Complications in Multiple Myeloma (MM) Patients J Kort, F Oley, N Naleid, L Metheny, M Gallogly, E Malek, B Cooper Clinical Lymphoma Myeloma and Leukemia 23, S508, 2023 | | 2023 |
| POSTER: MM-537 Impact of Melphalan Dose and CD34+ Cell Infusion on Engraftment and Post-Transplant Complications in Multiple Myeloma (MM) Patients J Kort, F Oley, N Naleid, L Metheny, M Gallogly, E Malek, B Cooper Clinical Lymphoma Myeloma and Leukemia 23, S222, 2023 | | 2023 |
| FISH abnormalities in Agent Orange–associated multiple myeloma. J Kort, T O'Brien Journal of Clinical Oncology 41 (16_suppl), e20056-e20056, 2023 | | 2023 |
| Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of Stamina Trial E Malek, J Kort, L Metheny, P Fu, G Li, P Hari, Y Efebera, MH Qazilbash, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
| Dose Adjustment of Melphalan Is Safe and Effective for Certain Patients with MM Undergoing ASCT J Kort, F Oley, N Naleid, L Metheny, M Gallogly, E Malek, B Cooper 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | | 2023 |
| Artificial Intelligence to Assess the Systemic Impact of Malignant Plasma Cell Clone in Patients with Plasma Cell Dyscrasia E Malek, J Kort, GM Wang, C Tatsuoka, JJ Driscoll Blood 140 (Supplement 1), 7856-7857, 2022 | | 2022 |
